BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Kaletra 100mg/25mg tablets 0503010G0BBADAD	Kaletra	Lopinavir and ritonavir	Infections	No data available
Kaletra 133.3mg/33.3mg capsules 0503010G0BBAAAA	Kaletra	Lopinavir and ritonavir	Infections	No data available
Kaletra 200mg/50mg tablets 0503010G0BBACAC	Kaletra	Lopinavir and ritonavir	Infections	No data available
Kaletra 80mg/20mg/1ml oral solution 0503010G0BBABAB	Kaletra	Lopinavir and ritonavir	Infections	No data available
Kaliumjodid 65mg tablets (Imported (Germany) 0602020I0BCAAAT	Kaliumjodid (Antithyroid)	Potassium iodide	Endocrine System	No data available
Kalms Day 26mg tablets 091200000BFXUGB	Proprietary compound preparation BNF 0912000	Other health supplement preparations	Nutrition and Blood	No data available
Kalms Sleep tablets 091200000BFJPA0	Proprietary compound preparation BNF 0912000	Other health supplement preparations	Nutrition and Blood	No data available
Kalten capsules 0204000F0BBAAAA	Kalten	Atenolol with diuretic	Cardiovascular System	No data available
Kalydeco 25mg granules sachets 0307000S0BBADAD	Kalydeco	Ivacaftor	Respiratory System	No data available
Kalydeco 50mg granules sachets 0307000S0BBABAB	Kalydeco	Ivacaftor	Respiratory System	No data available
Kalydeco 75mg granules sachets 0307000S0BBACAC	Kalydeco	Ivacaftor	Respiratory System	No data available
Kamillosan baby cream 130201000BBBTA0	Proprietary compound emollients	Other emollient preparations	Skin	No data available
Kamillosan Chamomile 10.5% ointment 130201000BBBYAQ	Proprietary compound emollients	Other emollient preparations	Skin	No data available
Kanavit 20mg/ml oral drops sugar free 0906060Q0BDABAY	Kanavit	Phytomenadione	Nutrition and Blood	No data available
Kanjinti 150mg pdr for concentrate for inf vials 0801050ADBFAAAA	Kanjinti	Trastuzumab	Malignant Disease and Immunosuppression	No data available
Kanjinti 420mg pdr for concentrate for inf vials 0801050ADBFABAE	Kanjinti	Trastuzumab	Malignant Disease and Immunosuppression	No data available
Kanuma 20mg/10ml concentrate for solution for infusion vials 0908010ANBBAAAA	Kanuma	Sebelipase alfa	Nutrition and Blood	No data available
Kao-C junior diarrhoea oral suspension 0104010H0BEAAAL	Kao-C	Kaolin light	Gastro-Intestinal System	No data available
Kaodene oral suspension 0104020D0BBAAAB	Kaodene	Codeine phosphate compound mixtures	Gastro-Intestinal System	No data available
Kaolin 400mg / Calcium carbonate 75mg tablets 0104010H0AAAKAK	Kaolin light	Kaolin light	Gastro-Intestinal System	No data available
Kaolin 500mg/5ml / Calcium carbonate 250mg/5ml susp SF 0104010H0AAALAL	Kaolin light	Kaolin light	Gastro-Intestinal System	No data available
Kaolin heavy 20.76% / Zinc oxide 4.5% cream 1302010H0AAAAAA	Fuller's earth (Cream)	Fuller's earth	Skin	No data available
Kaolin light 1.5g/5ml / Codeine 5mg/5ml susp sugar free 0104020D0AAABAB	Codeine phosphate (Compound preparations)	Codeine phosphate compound mixtures	Gastro-Intestinal System	No data available
Kaolin light powder 190400000AALKLK	Generic compound preparation BNF 1904000	Other single substance preparations	Other Drugs and Preparations	No data available
Kaolin mixture 0104010H0AAABAB	Kaolin light	Kaolin light	Gastro-Intestinal System	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.